The Centers for Disease Control and Prevention (CDC) and Food and Drug Administration (FDA) are announcing the following public virtual workshop entitled ‘Drug Development Considerations for the Prevention of HealthCare-Associated Infections’.
Date: August 30, 2022
Time: 8:30 a.m. – 5 p.m. EDT
DESCRIPTION AND SUMMARY
Discussions are planned around the following topics/areas:
- The current state of development of pathogen-directed products used to prevent healthcare-associated infections
- Evidence supporting decolonization and pathogen reduction (in colonized patients) as a strategy to prevent infection and transmission of antimicrobial-resistant healthcare-associated pathogens
- Antimicrobial resistance threats as potential targets for decolonization and pathogen reduction
- Challenges and potential approaches to drug development and registration of products for the prevention of healthcare-associated infections
Registration link here
All meeting materials—including agenda, panelist affiliations/disclosures, speaker slides, workshop recording, and transcript—will be posted here shortly before and/or after the completion of the workshop.